Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
methylcobalamin + alpha lipoic acid + benfotiamine + inositol + chromium picolinate
- Development stage
- Unknown
- Lead developer
- Saltvae Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Methylcobalamin + alpha lipoic acid + benfotiamine + inositol + chromium picolinate is a fixed-dose combination nutraceutical product manufactured by Saltvae Pharmaceuticals. It is primarily indicated for the management of diabetic and peripheral neuropathy, as well as for supporting metabolic health. Methylcobalamin, a bioactive form of Vitamin B12, is essential for neuronal myelin sheath synthesis and nerve regeneration. Alpha-lipoic acid serves as a potent antioxidant that reduces oxidative stress in nerve tissues. Benfotiamine, a lipid-soluble derivative of thiamine (Vitamin B1), helps prevent nerve damage by inhibiting advanced glycation end-product (AGE) formation. Inositol contributes to nerve conduction and cellular signaling, while chromium picolinate enhances insulin sensitivity and glucose metabolism. This combination is typically administered orally in tablet form.
- Other names
- Methylcobalamine, Alpha Lipoic Acid, Benfotiamine Inositol, Chromium Picolinate Tablets
02
Targets
MTR (Methionine synthase)INSR (Insulin receptor)TKT (Transketolase)
Beyond the preview
Go deeper on methylcobalamin + alpha lipoic acid + benfotiamine + inositol + chromium picolinate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on methylcobalamin + alpha lipoic acid + benfotiamine + inositol + chromium picolinate.